POLISCOPE
Topic33 documents tagged

Drug Pricing

What This Page Covers

This page collects the 33 public records POLISCOPE has tagged with “Drug Pricing”. Coverage spans bills - each decoded into plain English and linked to its primary source. It most often overlaps with Healthcare, Pharmaceuticals, and Pharmaceutical Industry.

Active Bills

Federal BillFEDERALDec 17, 2024Maintaining Investments in New Innovation Act (H.R. 5547)This bill extends the period of time that certain advanced, genetically targeted drugs are protected from government price negotiations under the Social Security Act. It increases the exclusivity periFederal BillFEDERALDec 17, 2024Proposed Changes to Medicare Pharmacy Performance Standards

Recent Activity

No recent activity found for this topic in the available records yet.

Browse recent local activity →

Finance Signals

No finance signals found for this topic in the available records yet.

Trace money trail →

Open the Money page to search by entity, donor, or PAC.

Reported financial relationships and timing signals. This does not prove motive or influence.

Key Actors

  1. 01Ron Wydenperson2 mentions
  2. 02Grassley, Chuckperson2 mentions
  3. 03Centers for Medicare & Medicaid Servicesorganization2 mentions
  4. 04Kendall Cairnsperson1 mentions
  5. 05Mark Millerperson1 mentions
  6. 06Inflation Reduction Actconcept1 mentions
  7. 07Mr. Nickelperson1 mentions
  8. 08Mr. Carter of Georgiaperson1 mentions
  9. 09Optumrxorganization1 mentions
  10. 10Express Scriptsorganization1 mentions

Connections Preview

Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.

  • Topic to billsMaintaining Investments in New Innovation Act (H.R. 5547), Proposed Changes to Medicare Pharmacy Performance Standards
  • Topic to peopleRon Wyden, Grassley, Chuck, Kendall Cairns (+3 more)
  • Topic to orgsCenters for Medicare & Medicaid Services, Optumrx, Express Scripts
Open the relationship graph →

Source Trail

Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.

  1. Jul 20, 2026lobbying filingLobbying Report: 340B Health (Q2 2026)
  2. Dec 17, 2024Federal BillMaintaining Investments in New Innovation Act (H.R. 5547)
  3. Dec 17, 2024Federal BillProposed Changes to Medicare Pharmacy Performance Standards
  4. Jan 1, 2024hearing transcriptHearing on Barriers to Medical Innovation and Patient Access
  5. Jan 1, 2022hearing transcriptSenate Hearing: Why U.S. Prescription Drug Prices Are the Highest in the World
  6. Jan 1, 2021hearing transcriptHouse Subcommittee Hearing on Drug Pricing Transparency
  7. Jan 1, 2020hearing transcriptCongressional Hearing on Rising Insulin Costs
  8. Jan 1, 2020hearing transcriptSenate Hearing: Drug Pricing in America
  9. Jan 1, 2019hearing transcriptCongressional Hearing on 340B Drug Pricing Program Improvements
  10. Jan 1, 2019hearing transcriptSenate Hearing on Prescription Drug Pricing

Showing 10 of 33 source records.